Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases
Launched by BEIJING ANZHEN HOSPITAL · Jun 1, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the outcomes of different treatment options for people with specific heart and brain-related diseases, including conditions that occur after cardiac surgery. The researchers want to understand which treatments work best and what factors might lead to poor results. This information can help improve care for patients with these serious health issues.
To participate in this study, you must be at least 18 years old and have either neuro-co-cardiological diseases or have experienced cerebrovascular issues after heart surgery. The trial is currently looking for participants, and anyone who joins can expect to help researchers learn more about how to better manage these conditions. However, if a person's expected survival is less than one year or if they have other serious illnesses at the same time, they would not be eligible for this trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥18 years;
- • 2. Patients with neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases.
- Exclusion Criteria:
- • 1. The expected survival is less than 1 years;
- • 2. Simultaneously merge other serious diseases;
About Beijing Anzhen Hospital
Beijing Anzhen Hospital is a leading medical institution in China, renowned for its expertise in cardiovascular diseases and comprehensive healthcare services. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and innovation, facilitating the development of new therapies and treatment protocols. With a focus on patient safety and ethical standards, Beijing Anzhen Hospital collaborates with various research entities to conduct rigorous clinical studies aimed at improving patient outcomes and enhancing the understanding of cardiovascular health. Its commitment to excellence in clinical research is underscored by a multidisciplinary team of experienced healthcare professionals and a state-of-the-art facility equipped to support a wide range of clinical investigations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported